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Polymorphisms in IL-1 gene have been suggested to inﬂuence transcription of IL-1α and IL-1B and thereby the pathophysiology
of periodontitis. Using genotyping IL-1 test, a pilot study was conducted on 32 Syrian patients with aggressive periodontitis (AgP)
and 35 healthy controls to investigate the association between the IL-1α(−889), IL-1B(+3953) gene polymorphisms and AgP
among schoolchildren. The results revealed a similar distribution of genotypes between patients and controls, and did not support
an association between IL-1 gene polymorphisms and AgP, however, the association was signiﬁcant in male patients only. To
determine and conﬁrm any susceptible or resistant genes for AgP, future studies should use many target genes and well-deﬁned
related periodontal outcomes.
1.Introduction
Periodontitis is an opportunistic inﬂammatory disease of
the periodontium. It is widely regarded as one of the most
common diseases worldwide. Aggressive periodontitis (AgP)
comprises a group of rare periodontal diseases characterized
by frequently severe clinical manifestations that aﬀect young
individuals, progress rapidly, and can involve multiple family
members. Although the presence of bacteria is essential for
the onset of the disease, the number and type of these
microorganisms are not suﬃcient to explain diﬀerences in
the inﬂammatory and immune responses and consequently,
in the severity of the periodontal disease [1]. In recent years,
studies have demonstrated that periodontitis is associated
with elevated levels of inﬂammatory cytokines [2], which
have a substantial impact on numerous biological activities,
and they are taking part in triggering inﬂammatory cascades
and systems [3]. Interleukin-1 (IL-1) is considered a major
mediator of periodontal inﬂammation. It aﬀects nearly
every cell type, often in concert with other cytokines or
small mediator molecules (e.g., phospholipase A2 type
II, cyclooxygenase-2(cox2)). However, the varied biological
properties of IL-1 result from its eﬀects on the expression
of various genes that regulate the production of the other
cytokines [4]. IL1 modulates extracellular matrix compo-
nents, enhances bone resorption in the periodontal tissues,
stimulates ﬁbroblasts and other nucleated cells to produce
matrix metalloproteinase, activates plasminogen, and trig-
gersprostaglandinsynthesis[5].IL-1alsostronglystimulates
connective tissue catabolism, activates immunocytes, and
regulates adhesion molecules that facilitate migration of
leukocytes into tissues [6]. IL-1 family genes are located in
a cluster on human chromosome 2q13, a speciﬁc genotype
in the IL-1 cluster that includes a speciﬁc locus is associated
with increased IL-1 production and increased susceptibility
to periodontitis [7].
It has currently become evident that in the case of most
diseases other factors exist, and those factors do not cause
disease but they modify its course, rendering it more severe.
Among these factors are genetic alterations, called polymor-
phisms, which are commonly found in the population [8].
Gene polymorphisms are locations within the genome that
vary in sequence between individuals and are very prevalent,
aﬀecting at least 1% of the population [9]. Many genes
responsible for cytokine production exhibit polymorphisms
which can modify the production of cytokines such as IL-12 ISRN Dentistry
[10].Polymorphisms in various cytokine genescaninﬂuence
the level of secretion of these substance and explain the vari-
ations in individual immune-inﬂammatory responses to a
bacterial virulence [8]. Recent studies have indicated that the
IL-1 gene polymorphism might be associated with a greater
severity of the disease in patients with AgP [11]. More than
99% of the African American patients of localized juvenile
periodontitis (LJP) exhibit polymorphism of IL1B(+3953)
allele1[12].Therewasaclearinﬂuenceofthepolymorphism
of genes IL-1B(+3954), IL-1α(−889), and IL6(−147) on the
AgP susceptibility [13]. On the other hand, there was not any
signiﬁcant association of the polymorphism of IL-1genes
with the AgP infection in Japan [14].
The objective of the present study was to investigate
the association between the IL-1α(−889), IL-1B(+3953)
gene polymorphisms and aggressive periodontitis among
schoolchildren in Syria.
2.MaterialsandMethods
The study protocol was approved by the Research Ethics
Committee of the Faculty of Dentistry, Damascus University.
Sixty seven students distributed into AgP patients and
healthycontrolshavingbeenselectedfromsimilargeograph-
ical areas, had a similar socioeconomic status, participated
in the study after providing informed consent and being
advised about their disease. Evaluation of each participant
consisted of personal and family medical and dental his-
tory, panoramic radiographs, and periodontal examinations.
Subjects were free of systemic diseases, and those who
were smokers used anti-inﬂammatory or antibiotic drugs
in the last three months, or used orthodontic devices were
excluded. Moreover, all of participants had at least 24 teeth.
The AgP group is comprised of 32 Syrian patients
(11 males and 21 females), aged 12–20 years (mean =
14.6), from the Department of Periodontology, Faculty of
Dentistry, Damascus University. A clinical diagnosis of LAgP
was made for 8 patients, while 24 patients were diagnosed
as having GAgP according to the criteria of the IWC 1999
International Workshop for a Classiﬁcation of Periodon-
tal Diseases and Conditions [15]. The following clinical
parameters: probing depth (PD), clinical attachment loss
(CAL), and bleeding on probing (BOP) were recorded at six
sites (mesiobuccal, buccal, distobuccal, mesiolingual/palatal,
palatal/lingual, distopalatal/lingual) for each tooth using a
Williams Periodontal Probe (Carl Martin, Solingen, Ger-
many), while Gingival index (GI), and plaque index (PI)
were recorded at four sites (mesiobuccal, buccal, distobuccal,
lingual/palatal).
The control group consisted of 35 healthy students (20
males and 15 females), aged 12–20 years (mean = 15.3), and
who do not have a clinical evidence of attachment loss in any
tooth after recording (CAL, PD, BOP) indices at the previous
six sites.
3. Sample Collection andGenotypingAnalysis
One buccal swab sample was obtained from each individual
by moving it on the interior surface of the cheek for 20–30
seconds, extra saliva was dried by using a hand fan for one
minute. Genotyping IL-1 tests were achieved in cooperation
with the Hain Lifescience Laboratory, Germany, and based
on the DNA·STRIP technology which permits the combined
characterization of polymorphisms at position (−889) of the
human (IL-1α) gene, and position (+3953) of the human
(IL-1B) gene. The whole procedure was divided into three
steps: DNA extraction from a patient sample (buccal swab),
a multiplex ampliﬁcation with biotinylated primers, and a
reverse hybridization.
The hybridization included the following steps: chemical
denaturation of the ampliﬁcation products, hybridization of
the single-stranded, biotin-labeled amplicons to membrane-
bound probes, stringent washing, addition of a strepta-
vidin/alkaline phosphatase (AP) conjugate, and an AP-
mediated staining reaction.
4.StatisticalAnalysis
Todeterminewhetheranysigniﬁcantdiﬀerencesinpolymor-
phism frequencies occurred between the AgP and control
populations, and according to both genders, data analyses
were performed using computer program (SPSS 10.0 for
Windows, Chicago, Ill, USA). We compared allele and
genotype frequencies, using Fisher’s exact test. The strength
of the associations was determined using odds ratio (OR)
calculations and 95% conﬁdence intervals (CIs).
5. Results
AgP patients had a mean probing depth of 5.1 ± 1.1mm
and clinical attachment loss of 6.8 ± 2.6mm (at aﬀected
teeth); control individuals had a mean probing depth of
1.8 ±0.5mm and without any clinical attachment loss.
T h eh o m o z y g o u sI L - 1 α(−889) allele 1 was present in
57.1% of the control group and in 37.5% of AgP group,
homozygous IL-1α(−889) allele 2 was present in 8.6%
of the control group and in 12.5% of AgP group, while
the heterozygous IL-1α(−889) allele (1,2) was present in
34.3% of the control group and in 50% of AgP group. The
diﬀerences between the two groups were not signiﬁcant as
analyzed with Fisher’s Exact test (P = 0.274), Table 1.
The frequency of IL-1α(−889) allele 1 and allele 2 was
74.3% and 25.7%, respectively, in control group, and in the
AgP group the frequency for allele 1 was 62.5% and 37.5%
for allele 2. The diﬀerences between two groups were not
signiﬁcant;ORforIL-1α(−889)allele2intheAgPgroupwas
1.733 (95% CI (0.829–3.623), P = 0.19), Table 1.
However, for IL-1B(+3953), genotype frequencies in
the control group were 62.8% for genotype (1,1), 22.9%
for genotype (2,1) (heterozygous), and 14.3% for geno-
type (2,2). Statistically similar genotype frequencies were
obtained for the AgP groups: 46.9% for genotype (1,1),
43.7% for genotype (2,1), and 9.4% for genotype (2,2).
The diﬀerences between two groups were not signiﬁcant as
analyzed with Fisher’s Exact test (P = 0.194), Table 2.
The frequency of allele 1 and allele 2 was 74.3%
and 25.7% in control group, and in the AgP group the
frequency for allele 1 was 68.8%, and for allele 2 was 31.2%.ISRN Dentistry 3
Table 1: Frequency of IL-1α(−889) genotype and allele in AgP
patients and healthy controls.
IL-1α(−889)
Group
AgP Control
N % N %
1,1 12 37.5 20 57.1
2,2 4 12.5 3 8.6
1,2 16 50 12 34.3
Total 32 100 35 100
Allele 1 40 62.5 52 74.3
Allele 2 24 37.5 18 25.7
Total 64 100 70 100
Table 2: Frequency of IL-1B(+3953) genotype and allele in AgP
patients and healthy controls.
IL-1B(+3953)
Group
AgP Control
N % N %
1,1 15 46.9 22 62.8
2,2 3 9.4 5 14.3
1,2 14 43.7 8 22.9
Total 32 100 35 100
Allele 1 44 68.8 52 74.3
Allele 2 20 31.2 18 25.7
Total 64 100 70 100
The diﬀerences between two groups were not signiﬁcant; OR
for IL-1B(+3953) allele 2 in the AgP group was 1.313 (95%
CI (0.619–2.788), P = 0.566), Table 2.
The homozygous IL-1α(−889) allele 1 was present in
60%ofthemalesincontrolgroupandin9.1%ofthemalesin
A g Pg r o u p ,h o m o z y g o u sI L - 1 α(−889) allele 2 was present in
5%ofthemalesincontrolgroupandin18.2%ofthemalesin
AgP group, while the heterozygous IL-1α(−889) allele (1,2)
was present in 35% of the males in control group and in
72.7% of the males in AgP group. The diﬀerences between
two groups were signiﬁcant as analyzed with Fisher’s Exact
test (P = 0.012), Table 3.
The frequencies of IL-1α(−889) genotypes among the
females in AgP and control groups were very similar, and the
comparison revealed no signiﬁcant association as analyzed
with Fisher’s Exact test (P = 1.0), Table 3.
The homozygous IL-1B(+3953) allele 1 was present in
75% of the males in control group and in 27.3% of the males
inAgPgroup,homozygousIL-1B(+3953)allele2waspresent
in15%ofthemalesincontrolgroupand9.1%ofthemalesin
AgP group, while the heterozygous IL-1B(+3953) allele (1,2)
was present in 10% of the males in control group and in
63.6% of the males in AgP group. The diﬀerences between
two groups were signiﬁcant as analyzed with Fisher’s Exact
test (P = 0.006), Table 4.
The frequencies of IL-1B(+3953) genotypes among the
females in AgP and control groups were very similar, and the
Table 3: Distribution of IL-1α(−889) genotype in AgP patients and
healthy controls according to the gender.
IL-1α(−889)
Male Female
AgP Control AgP Control
n % N % N % n %
1,1 1 ∗9.1 12 60 11 52.4 8 53.3
2,2 2 ∗18.2 1 5 2 9.5 2 13.3
1,2 8 ∗72.7 7 35 8 38.1 5 33.3
Total 11 100 20 100 21 100 15 100
Table 4: Distribution of IL-1B(+3953) genotype in AgP patients
and healthy controls according to the gender.
IL-1B(+3953)
Male Female
AgP Control AgP Control
n % n % n % n %
1,1 3 ∗∗27.3 15 75 12 57.1 7 46.7
2,2 1 ∗∗9.1 3 15 2 9.5 2 13.3
1,2 7 ∗∗63.6 2 35 7 33.3 6 40
Total 11 100 20 100 21 100 15 100
∗∗P<0.01
comparison revealed no signiﬁcant association as analyzed
with Fisher’s Exact test (P = 0.895), Table 4.
6. Discussion
Aggressive periodontitis is a multifactorial disease resulting
from the complex interactions between the host, microor-
ganisms, and environment. In recent years, studies have
demonstrated that periodontitis is associated with elevated
levels of a variety of inﬂammatory biomarkers. Furthermore,
genetic variants of some cytokines confer susceptibility to
periodontitis.
The prevalence of AgP among young Syrian population
was reported to be 2.8%, and considered very high when
compared to the other populations [16]. Therefore, 32
Syrian AgP patients and 35 healthy control individuals
were recruited. The AgP and control groups were similar
regarding age distribution. Nonsmokers and former smokers
were included since smoking has been identiﬁed as the
major environmental risk factor associated with increased
incidence and severity of periodontitis [17].
Genetic studies of world populations support the cat-
egorization into ﬁve major groups: Africans, Caucasians,
Paciﬁc Islanders, East Asians, and Native Americans [18].
Furthermore, population clusters identiﬁed by genotype
analysis seem to be more informative than those identiﬁed
by skin color or self-declaration of race [19].
Syrians belong to the Caucasian group, and the literature
contains no other data regarding the association of IL-1gene
polymorphisms with AgP in Syrian population. The allele
and genotype distributions observed in the both groups were
similar to those previously reported in Caucasian popula-
tions. However, our results demonstrated that there was no4 ISRN Dentistry
signiﬁcant association between AgP and the IL-1α(−889)
andIL-1B(+3953)genepolymorphismsinpatientswithAgP.
Theﬁndingspresentedheredisagreewiththeresultspro-
vided by Brett et al. [20] which pointed to a strong evidence
of association between IL-1B(+3953) gene polymorphism
and AgP. Guzeldemir et al. [21] reported that IL-1 gene
polymorphisms appeared to have a role in susceptibility to
LAgP in the Turkish population. The present results agree
with those reported by other investigators studying patients
withAgP. For example, Gonzaleset al. [22]failedtodetectan
association with IL-1 genotypes in European Caucasians and
Central Americans with AgP. Also Scapoli et al. [23] did not
support the existence of a causative variant for generalized
AgP within the 2q13-14 region in an Italian Caucasian
population. Finally, Fiebig et al. [24] did not report an
association betweenvariants intheIL-1geneclusterand AgP
in northern European Caucasian patients.
The results showed a signiﬁcant association between
AgP and the IL-1α(−889) and IL-1B(+3953) gene polymor-
phismsinmalepatientsonly,whichindicatesthatmaleswere
more sensitive to the genetic variations, and this could be
attributed to the diﬀerences in prevalence of genetic poly-
morphisms between both genders. This result corresponds
with the study of Gera and v´ ari [25] which found that the
association between diﬀerent candidate gene polymorphism
and its periodontal eﬀects is still very controversial, and
certain associations are dependent on sex and race.
In literature, AgP was generally found to be more
common in females than males, and this might be explained
by the fact that females tend to be more concerned to
their appearance and more likely to seek dental attention
than males. Another possible reason is the earlier age of
puberty in females; hormonal changes during the menstrual
cycle and pregnancy might aggravate the clinical course
of the disease [26]. While many studies have shown the
association between the inﬂuence of gene polymorphisms on
many other diseases and the gender, for example, Queiroz
et al. [27] reported that increasing age, male sex, and IL1
gene polymorphisms were independently associated with
duodenal ulcer. However, no conﬁdent data are available
about the above- mentioned association in periodontal
diseases, which necessitates a study of the relation between
sex and the impact of gene polymorphisms on AgP.
The diﬃculty in associating gene polymorphisms with
AgP might be explained by the lack of higher expression of
a single gene in the disease. Probably, there are other genes
altering the expression of genes and inﬂuencing the clinical
expression of the disease. Furthermore, multiple polymor-
phisms might be necessary for an increase in the severity
of the disease. In addition, speciﬁc genes may vary among
diﬀerent populations and/or ethnic groups, and true hetero-
geneity in the susceptibility to the disease might be present.
In conclusion, the present study revealed no association
between the IL-1α(−889) and IL-1B(+3953) gene polymor-
phisms and AgP in Syrian population, in the absence of the
other risk factors, whilet the results indicate the need to
future studies which may contribute to the investigation of
the eﬀect of sex on the previous associations.
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